(VIANEWS) – AGNC Investment Corp. (AGNC), Tekla Healthcare Investors (HQH), ClearBridge Energy MLP Fund (CEM) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| AGNC Investment Corp. (AGNC) | 15.03% | 2024-03-03 16:55:20 |
| Tekla Healthcare Investors (HQH) | 9.71% | 2024-02-29 13:11:06 |
| ClearBridge Energy MLP Fund (CEM) | 8.74% | 2024-02-27 23:46:07 |
| Gerdau S.A. (GGB) | 7.06% | 2024-02-29 05:08:05 |
| Gladstone Investment Corporation (GAIN) | 7.02% | 2024-03-05 23:47:05 |
| W.P. Carey REIT (WPC) | 6.1% | 2024-03-03 10:55:17 |
| Gilead Sciences (GILD) | 4.1% | 2024-03-12 15:12:34 |
| Dreyfus Strategic Municipals (LEO) | 4.06% | 2024-03-01 01:23:06 |
| Banco Santander (SAN) | 3.59% | 2024-03-12 14:59:06 |
Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. AGNC Investment Corp. (AGNC) – Dividend Yield: 15.03%
AGNC Investment Corp.’s last close was $9.58, 11.95% under its 52-week high of $10.88. Intraday change was 0.21%.
AGNC Investment Corp. operates as a real estate investment trust (REIT) in the United States. It invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency. The company funds its investments primarily through collateralized borrowings structured as repurchase agreements. It has elected to be taxed as a REIT under the Internal Revenue Code of 1986 and would not be subject to federal corporate income taxes, if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as American Capital Agency Corp. and changed its name to AGNC Investment Corp. in September 2016. AGNC Investment Corp. was incorporated in 2008 and is headquartered in Bethesda, Maryland.
Earnings Per Share
As for profitability, AGNC Investment Corp. has a trailing twelve months EPS of $0.05.
PE Ratio
AGNC Investment Corp. has a trailing twelve months price to earnings ratio of 191.6. Meaning, the purchaser of the share is investing $191.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.92%.
More news about AGNC Investment Corp..
2. Tekla Healthcare Investors (HQH) – Dividend Yield: 9.71%
Tekla Healthcare Investors’s last close was $17.09, 6.46% below its 52-week high of $18.27. Intraday change was -0.91%.
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Earnings Per Share
As for profitability, Tekla Healthcare Investors has a trailing twelve months EPS of $1.09.
PE Ratio
Tekla Healthcare Investors has a trailing twelve months price to earnings ratio of 15.54. Meaning, the purchaser of the share is investing $15.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.1%.
More news about Tekla Healthcare Investors.
3. ClearBridge Energy MLP Fund (CEM) – Dividend Yield: 8.74%
ClearBridge Energy MLP Fund’s last close was $42.33, 1.28% under its 52-week high of $42.88. Intraday change was 0.26%.
ClearBridge Energy MLP Fund Inc. is a closed-ended equity mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC. It is co-managed by Clearbridge Advisors, LLC. The fund invests in the public equity markets of the United States. It seeks to invest in stocks of companies operating in the energy sector. The fund primarily invests in equity securities of MLPs and growth stocks of companies operating across diversified market capitalizations. It employs fundamental analysis with a bottom-up stock selection approach, focusing on companies with long-lived assets, predictable cash flows, and low direct commodity exposure to create its portfolio. ClearBridge Energy MLP Fund Inc. was formed on March 31, 2010 and is domiciled in the United States.
Earnings Per Share
As for profitability, ClearBridge Energy MLP Fund has a trailing twelve months EPS of $-3.33.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Aug 23, 2023, the estimated forward annual dividend rate is 3.08 and the estimated forward annual dividend yield is 8.74%.
Moving Average
ClearBridge Energy MLP Fund’s value is higher than its 50-day moving average of $40.09 and way higher than its 200-day moving average of $36.58.
Yearly Top and Bottom Value
ClearBridge Energy MLP Fund’s stock is valued at $42.33 at 17:15 EST, under its 52-week high of $42.88 and way above its 52-week low of $29.22.
Volume
Today’s last reported volume for ClearBridge Energy MLP Fund is 25204 which is 51.52% below its average volume of 51993.
More news about ClearBridge Energy MLP Fund.
4. Gerdau S.A. (GGB) – Dividend Yield: 7.06%
Gerdau S.A.’s last close was $4.30, 30.19% under its 52-week high of $6.16. Intraday change was -1.15%.
Gerdau S.A., together with its subsidiaries, operates as a steel producer company in the Americas. The company operates through Brazil Business, North America Business, South America Business, and Special Steel Business divisions. It provides semi-finished products, including billets, blooms, and slabs; common long rolled products, such as rebars, wire rods, merchant bars, light shapes, and profiles to the construction and manufacturing industries; drawn products comprising barbed and barbless fence wires, galvanized wires, fences, concrete reinforcing wire mesh, nails, and clamps for manufacturing, construction, and agricultural industries; and special steel products used in auto parts, light and heavy vehicles, and agricultural machinery, as well as in the oil and gas, wind energy, machinery and equipment, mining and rail, and other markets. The company also offers flat products, such as hot-rolled steel coils and heavy plates; and resells flat steel products. In addition, it operates three mines that produce iron ore located in the Brazilian state of Minas Gerais. The company sells its products through independent distributors, direct sales from the mills, and its retail network. The company was founded in 1901 and is based in São Paulo, Brazil.
Earnings Per Share
As for profitability, Gerdau S.A. has a trailing twelve months EPS of $0.9.
PE Ratio
Gerdau S.A. has a trailing twelve months price to earnings ratio of 4.78. Meaning, the purchaser of the share is investing $4.78 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.78%.
Moving Average
Gerdau S.A.’s value is under its 50-day moving average of $4.46 and way below its 200-day moving average of $4.86.
Revenue Growth
Year-on-year quarterly revenue growth declined by 18.1%, now sitting on 68.92B for the twelve trailing months.
More news about Gerdau S.A..
5. Gladstone Investment Corporation (GAIN) – Dividend Yield: 7.02%
Gladstone Investment Corporation’s last close was $13.63, 8.89% under its 52-week high of $14.96. Intraday change was -0.37%.
Gladstone Investment Corporation is business development company, specializes in lower middle market, mature stage, buyouts; refinancing existing debt; senior debt securities such as senior loans, senior term loans, lines of credit, and senior notes; senior subordinated debt securities such as senior subordinated loans and senior subordinated notes; junior subordinated debt securities such as subordinated notes and mezzanine loans; limited liability company interests, and warrants or options. The fund does not invest in start-ups. The fund seeks to invest in manufacturing, consumer products and business/consumer services sector. It seeks to invest in small and mid-sized companies based in the United States. The fund prefers to make debt investments between $5 million and $30 million and equity investments between $10 million and $40 million in companies. The fund seeks to invest in companies with revenue between $20 million and $100 million. The fund invests in companies with EBITDA from $3 million to $20 million. It seeks minority equity ownership and prefers to hold a board seat in its portfolio companies. It also prefers to take majority stake in its portfolio companies. The fund typically holds the investments for seven years and exits via sale or recapitalization, initial public offering, or sale to third party.
Earnings Per Share
As for profitability, Gladstone Investment Corporation has a trailing twelve months EPS of $1.98.
PE Ratio
Gladstone Investment Corporation has a trailing twelve months price to earnings ratio of 6.88. Meaning, the purchaser of the share is investing $6.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.82%.
Volume
Today’s last reported volume for Gladstone Investment Corporation is 95417 which is 56.98% below its average volume of 221803.
More news about Gladstone Investment Corporation.
6. W.P. Carey REIT (WPC) – Dividend Yield: 6.1%
W.P. Carey REIT’s last close was $56.36, 30.4% below its 52-week high of $80.98. Intraday change was 0.05%.
Celebrating its 50th anniversary, W. P. Carey ranks among the largest net lease REITs with an enterprise value of approximately $23 billion and a well-diversified portfolio of high-quality, operationally critical commercial real estate, which includes 1,475 net lease properties covering approximately 180 million square feet and a portfolio of 85 self-storage operating properties, as of June 30, 2023. With offices in New York, London, Amsterdam and Dallas, the company remains focused on investing primarily in single-tenant, industrial, warehouse and retail properties located in the U.S. and Northern and Western Europe, under long-term net leases with built-in rent escalations.
Earnings Per Share
As for profitability, W.P. Carey REIT has a trailing twelve months EPS of $3.28.
PE Ratio
W.P. Carey REIT has a trailing twelve months price to earnings ratio of 17.18. Meaning, the purchaser of the share is investing $17.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
W.P. Carey REIT’s EBITDA is 11.39.
Sales Growth
W.P. Carey REIT’s sales growth is negative 7.4% for the current quarter and negative 10.8% for the next.
Yearly Top and Bottom Value
W.P. Carey REIT’s stock is valued at $56.36 at 17:15 EST, way below its 52-week high of $80.98 and way above its 52-week low of $50.30.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.6%, now sitting on 1.74B for the twelve trailing months.
More news about W.P. Carey REIT.
7. Gilead Sciences (GILD) – Dividend Yield: 4.1%
Gilead Sciences’s last close was $75.32, 14.28% under its 52-week high of $87.87. Intraday change was -0.32%.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.
Earnings Per Share
As for profitability, Gilead Sciences has a trailing twelve months EPS of $4.5.
PE Ratio
Gilead Sciences has a trailing twelve months price to earnings ratio of 16.68. Meaning, the purchaser of the share is investing $16.68 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.54%.
Yearly Top and Bottom Value
Gilead Sciences’s stock is valued at $75.08 at 17:15 EST, way under its 52-week high of $87.87 and higher than its 52-week low of $71.37.
More news about Gilead Sciences.
8. Dreyfus Strategic Municipals (LEO) – Dividend Yield: 4.06%
Dreyfus Strategic Municipals’s last close was $6.01, 7.54% below its 52-week high of $6.50. Intraday change was 0.5%.
BNY Mellon Strategic Municipals, Inc. is a closed ended fixed income mutual fund launched and managed by BNY Mellon Investment Adviser, Inc. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade municipal bonds, the income from which is exempt from federal income tax. It employs fundamental analysis to create its portfolio. The fund was formerly known as Dreyfus Strategic Municipals, Inc. BNY Mellon Strategic Municipals, Inc. was formed on September 23, 1987 and is domiciled in the United States.
Earnings Per Share
As for profitability, Dreyfus Strategic Municipals has a trailing twelve months EPS of $0.04.
PE Ratio
Dreyfus Strategic Municipals has a trailing twelve months price to earnings ratio of 150.25. Meaning, the purchaser of the share is investing $150.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.31%.
Volume
Today’s last reported volume for Dreyfus Strategic Municipals is 127390 which is 45.75% below its average volume of 234838.
Revenue Growth
Year-on-year quarterly revenue growth declined by 2.3%, now sitting on 29.83M for the twelve trailing months.
More news about Dreyfus Strategic Municipals.
9. Banco Santander (SAN) – Dividend Yield: 3.59%
Banco Santander’s last close was $4.31, 0.47% higher than its 52-week high of $4.29. Intraday change was 2.09%.
Banco Santander, S.A. provides various financial services worldwide. The company operates through Retail Banking, Santander Corporate & Investment Banking, Wealth Management & Insurance, and PagoNxt segments. It offers demand and time deposits, mutual funds, and current and savings accounts; mortgages, consumer finance, loans, and various financing solutions; and corporate finance, global debt financing and market, global transaction banking, and private debt mobilization solutions. The company also provides asset management and private banking services; and insurance products. In addition, it offers corporate and investment banking services; and digital payment solutions. The company was formerly known as Banco Santander Central Hispano SA and changed its name to Banco Santander, S.A. in February 2007. Banco Santander, S.A. was founded in 1856 and is headquartered in Madrid, Spain.
Earnings Per Share
As for profitability, Banco Santander has a trailing twelve months EPS of $0.71.
PE Ratio
Banco Santander has a trailing twelve months price to earnings ratio of 6.2. Meaning, the purchaser of the share is investing $6.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.07%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.9%, now sitting on 44.76B for the twelve trailing months.
Moving Average
Banco Santander’s value is above its 50-day moving average of $4.06 and way above its 200-day moving average of $3.83.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Banco Santander’s stock is considered to be oversold (<=20).
Previous days news about Banco Santander
- Banco santander, s.a. investigated regarding potential securities law violations – contact levi & korsinsky for details- SAN. According to Business Insider on Sunday, 10 March, "A Financial Times article alleged Banco Santander was used by Iran to covertly move money around the world as part of a sanctions-evading scheme. ", "Following this news, on February 5, 2024, shares of Banco Santander S.A. stock dropped over 5% in premarket trading. "
More news about Banco Santander.
